SHPHNasdaqPharmaceutical PreparationsFiscal year ends December 31
Shuttle Pharmaceuticals Holdings, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Sep 24, 2026
$4.72−0.36 (-7.09%)
Close on Oct 19, 2026
- Market cap
- $4.79M
- P/E (TTM)
- –
- Dividend yield
- –
Shuttle Pharmaceuticals statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Shuttle Pharmaceuticals | Industry median |
|---|---|---|
| Market Cap | $22.49M | $197.05M |
| Enterprise Value | $22.40M | $106.56M |
| PB Ratio | 1.17 | 2.14 |
| P/TBV Ratio | 2.14 | 2.46 |
Income (trailing twelve months)
| Measure | Shuttle Pharmaceuticals | Industry median |
|---|---|---|
| Operating Income | -$11.22M | -$21.44M |
| Net Income | -$10.26M | -$22.46M |
| EBITDA | -$11.22M | -$16.91M |
Returns
| Measure | Shuttle Pharmaceuticals | Industry median |
|---|---|---|
| Return on Equity (ROE) | -90.1% | -53.1% |
| Return on Assets (ROA) | -72.5% | -41.0% |
| Return on Invested Capital (ROIC) | -99.2% | -32.0% |
| Return on Capital Employed (ROCE) | -58.1% | -37.8% |
Balance sheet
| Measure | Shuttle Pharmaceuticals | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $90.24K | $62.42M |
| Net Cash (Debt) | $90.24K | $15.68M |
| Net Cash Per Share | $0.02 | $0.65 |
| Equity (Book Value) | $19.18M | $48.79M |
| Book Value Per Share | $4.03 | $1.36 |
| Tangible Book Value | $10.53M | $23.06M |
| Working Capital | -$3.08M | $75.77M |
Financial position
| Measure | Shuttle Pharmaceuticals | Industry median |
|---|---|---|
| Current Ratio | 0.11 | 3.30 |
| Quick Ratio | 0.03 | 2.39 |
Cash flow (trailing twelve months)
| Measure | Shuttle Pharmaceuticals | Industry median |
|---|---|---|
| Operating Cash Flow | -$6.58M | -$12.35M |
Efficiency
| Measure | Shuttle Pharmaceuticals | Industry median |
|---|---|---|
| Profits Per Employee | -$5.13M | -$732.08K |
| Employee Count | 2 | 73 |
Dividends and yields
| Measure | Shuttle Pharmaceuticals | Industry median |
|---|---|---|
| Earnings Yield | -45.6% | -21.2% |
Shares
| Measure | Shuttle Pharmaceuticals | Industry median |
|---|---|---|
| Shares Outstanding | 4,764,700 | 59,128,900 |
| Shares Change (YoY) | 1007.5% | 11.1% |
| Shares Change (QoQ) | 80.3% | 0.54% |
| Float | 3,217,950 | 48,744,500 |
| Shares Held by Insiders | 32.5% | 11.8% |
| Shares Held by Institutions | 2.19% | 59.4% |
Scores
| Measure | Shuttle Pharmaceuticals | Industry median |
|---|---|---|
| Altman Z-Score | -1.23 | 0.10 |
| Piotroski F-Score | 3 | 4 |
Calculated by StockData from Shuttle Pharmaceuticals's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.